Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma

Overview of attention for article published in Biology of Blood & Marrow Transplantation, March 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy: 2 policy sources

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study

Cited by Centers for Disease Control and Prevention (CDC) on 07 Dec 2024

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

idecabtagene vicleucel - Clinical, Pharmacoeconomic, and Ethics combined Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 12 Nov 2021

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.